2026年全球比較採購市場報告

近年來，用於採購對比樣品的市場規模迅速擴張。預計該市場規模將從2025年的18.1億美元成長到2026年的19.5億美元，複合年成長率（CAGR）為7.6%。這一成長主要歸因於標準化參考產品的供應有限、對原研藥樣品進行對比的高度依賴、全球藥品檢驗法規結構的碎片化、學名藥核准需求的不斷成長以及醫藥研發外包的擴張。

預計未來幾年，對照樣品採購市場規模將強勁成長。預計到2030年，該市場將以7.8%的複合年成長率成長，達到26.3億美元。預測期內的成長要素包括：生物製藥和生物相似藥研發的日益複雜化、精準醫療和標靶治療的擴展、先進分析檢測技術的日益普及、跨區域監管協調的加強、全球臨床試驗網路的擴展以及分散式研究的推進。預測期內的關鍵趨勢包括：藥物研發中對監管級參考物質的需求不斷成長、將對照樣品採購外包給合約研究組織（CRO）的趨勢日益明顯、生物等效性和分析檢測要求的日益複雜化、新興市場全球臨床試驗活動的擴展以及藥物研發中標準化品質檢驗框架的日益普及。

臨床試驗的擴展預計將推動對照品採購市場的成長。臨床試驗是指精心設計的、涉及受試者的研究，旨在評估新的醫療程序、藥物或醫療設備在獲準廣泛使用前的安全性、有效性和副作用。臨床試驗的擴展是由對治療慢性複雜疾病的新型高效療法的需求不斷成長，以及製藥和生物技術公司在藥物研發和法規核准方面投入的增加所驅動的。對照品採購透過確保高品質的等效參考療法來支持臨床試驗，從而實現臨床實驗藥物與標準療法之間的準確比較，進而提高研究的有效性、監管合規性和臨床結果的可靠性。例如，根據英國製藥商協會（ 英國 ）統計，截至2024年12月，英國製藥業啟動的臨床試驗數量連續第二年成長，從2022年的411項增至2023年的426項。因此，臨床試驗的擴展正在推動對照品採購市場的成長。

在對照藥物採購市場中，領先企業正致力於開發創新舉措，例如集中式對照藥物採購計劃，以提高臨床試驗效率、減少採購延誤，並確保生物類似藥研發所需的參考生物製藥的可靠供應。集中式對照藥物採購計畫是一個整合系統，用於管理臨床試驗所需參考生物製藥相似藥臨床試驗中的採購和供應鏈瓶頸。該計劃透過將對照藥物採購、合規文件和試驗特定物流整合到統一的框架中，簡化了採購流程，並降低了參考生物製劑供應有限所帶來的風險。該計劃將支持獲取利妥Rituximab、曲妥珠單抗、Bevacizumab、Infliximab和Adalimumab等昂貴療法，這些療法對於腫瘤和自體免疫疾病領域的生物相似藥試驗至關重要。最終，這將加速生物相似藥的研發，並加劇高價藥物市場的競爭。

目錄

第1章：執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球採購市場比較：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 永續性、氣候技術、循環經濟
• 主要趨勢
  • 藥物研發中對監管級參考物質的需求日益成長。
  • 增加對比樣本採購業務外包給簽約研究機構的工作。
  • 生物等效性和分析測試要求的日益複雜化。
  • 擴大新興市場的全球臨床試驗活動
  • 在藥物研發中擴大採用標準化品質檢驗框架。

第5章 終端用戶產業市場分析

• 製藥公司
• 生技公司
• 受託研究機構
• 學術研究機構
• 監管機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球採購比較市場：PESTEL 分析
• 全球比價採購市場：規模、對比及成長率分析
• 全球比價採購市場表現：規模與成長，2020-2025年
• 全球比價採購市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 依產品類型
• 品牌藥、學名藥、生物相似藥、生物製藥
• 按治療區域
• 腫瘤學、心血管疾病、神經病學、感染疾病、免疫學、呼吸系統疾病及其他治療領域
• 透過採購方式
• 本地採購，全球採購
• 透過使用
• 臨床試驗、生物等效性試驗、研發等應用
• 最終用戶
• 製藥公司、生物技術公司、受託研究機構、學術和研究機構
• 按類型細分：品牌藥品
• 創新抗癌藥物、循環系統參考藥物、專利保護的特藥、中樞神經系統藥物
• 按類型細分：學名藥
• 口服固體製劑學名藥、注射學名藥、市售學名藥、低成本替代療法
• 按類型細分：生物相似藥
• 單株抗體生物相似藥、胰島素生物相似藥、自體免疫疾病生物相似藥及腫瘤生物相似藥。
• 按類型細分：生物製劑
• 重組蛋白療法、細胞和基因療法、疫苗和免疫療法、血漿衍生生物製藥

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 採購市場比較分析：競爭格局及市場佔有率（2024 年）
• 採購市場比較：公司估值矩陣
• 採購市場比較分析：公司簡介
  • Thermo Fisher Scientific Inc.
  • IQVIA Inc.
  • ICON Public Limited Company
  • Eurofins Scientific SE
  • Piramal Pharma Limited

第37章 其他大型企業和創新企業

• Almac Group Limited, Wasdell Group Limited, Clinigen Group plc, Inceptua Group BV, Ancillare LP, Veristat LLC, BAP Pharma Holding Limited, Oximio Group Limited, Tanner Pharma Group Limited, Spring BioSolution Ltd., N-SIDE SA

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年採購市場比較：提供新機會的國家
• 2030年比較採購市場：提供新機會的細分市場
• 2030年比較採購市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Comparator sourcing refers to the process of identifying, selecting, and acquiring comparable products or reference materials used for benchmarking, analytical testing, regulatory submissions, and quality validation within research and development environments. It involves assessing equivalence based on specifications, formulation, composition, or performance characteristics to ensure accurate comparison with innovator or reference standards.

The primary product types of comparator sourcing include branded drugs, generic drugs, biosimilars, and biologics. Branded drugs refer to originator reference medicines used in comparative clinical and regulatory studies to evaluate safety and efficacy against test products. These products are categorized by therapeutic areas including oncology, cardiovascular diseases, neurology, infectious diseases, immunology, respiratory diseases, and other therapeutic areas and are sourced through local sourcing and global sourcing. The key applications include clinical trials, bioequivalence studies, research and development, and others, while the end users include pharmaceutical companies, biotechnology companies, contract research organizations, and academic and research institutes.

Tariffs are influencing the comparator sourcing market by increasing the cost of imported reference standards, branded drugs, and biologic materials used for analytical testing and regulatory validation. This is disrupting global supply chains and creating delays in bioequivalence studies and clinical research activities, particularly in import-dependent regions such as Asia-Pacific and Latin America. Segments such as branded drugs, biosimilars, and biologics are most affected due to their high reliance on cross-border sourcing of specialized materials. However, tariffs are also driving local manufacturing of reference products, strengthening regional sourcing networks, and encouraging diversification of supplier bases, ultimately improving supply chain resilience in the long term.

The comparator sourcing market size has grown strongly in recent years. It will grow from $1.81 billion in 2025 to $1.95 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to limited availability of standardized reference products, high dependency on innovator drug samples for comparison, fragmented global regulatory frameworks for drug validation, rising demand for generic drug approvals, growth in pharmaceutical r&d outsourcing.

The comparator sourcing market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing complexity of biologics and biosimilar development, expansion of precision medicine and targeted therapies, rising adoption of advanced analytical testing technologies, stronger regulatory harmonization across regions, growth in global clinical trial networks and decentralized research. Major trends in the forecast period include rising demand for regulatory grade reference standards in pharmaceutical development, increasing outsourcing of comparator sourcing to contract research organizations, growing complexity of bioequivalence and analytical testing requirements, expansion of global clinical trial activities across emerging markets, increasing adoption of standardized quality validation frameworks in drug development.

The expansion of clinical trials is expected to propel the growth of the comparator sourcing market going forward. Clinical trials refer to carefully designed research studies conducted on human participants to evaluate the safety, effectiveness, and side effects of new medical treatments, drugs, or medical devices before they are approved for public use. The expansion of clinical trials is driven by increasing demand for new and more effective treatments for chronic and complex diseases, along with rising investments by pharmaceutical and biotechnology companies in drug development and regulatory approvals. Comparator sourcing supports clinical trials by ensuring the availability of high-quality equivalent reference treatments that enable accurate comparisons between investigational drugs and standard-of-care therapies, thereby improving study validity, regulatory compliance, and the reliability of clinical outcomes. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the expansion of clinical trials is driving the growth of the comparator sourcing market.

Leading companies operating in the comparator sourcing market are focusing on developing innovative initiatives, such as centralized comparator drug sourcing programs, to improve clinical trial efficiency, reduce procurement delays, and ensure reliable access to reference biologics required for biosimilar development. Centralized comparator drug sourcing programs are integrated systems that manage procurement and supply of reference drugs for clinical trials, helping ensure timely access, regulatory compliance, and smoother biosimilar development. For example, in February 2026, VRC Medical Services, a US-based pharmaceutical company, launched a dedicated comparator support program designed to help biosimilar clinical trials overcome sourcing and supply chain constraints. The program centralizes comparator sourcing, compliance documentation, and trial-specific logistics into a unified framework, enabling faster procurement timelines and reducing risks linked to limited availability of reference biologics. It supports access to high-cost therapies such as rituximab, trastuzumab, bevacizumab, infliximab, and adalimumab, which are critical for biosimilar trials in oncology and autoimmune disease areas, ultimately helping accelerate biosimilar development and improve market competition in high-cost drug categories.

In December 2024, Novo Holdings A/S, a Denmark-based life sciences investment company, acquired Catalent Inc. for $16.5 billion. Through this acquisition, Novo Holdings A/S aimed to strengthen its global pharmaceutical manufacturing and contract development capabilities by integrating Catalent's large-scale drug development, clinical supply, and advanced drug delivery technologies, thereby enhancing supply chain capacity and supporting the growing demand for biologics, injectables, and specialty medicines. Catalent Inc. is a US-based contract development and manufacturing organization (CDMO) that specializes in providing comprehensive global comparator sourcing services for clinical trials.

Major companies operating in the comparator sourcing market are Thermo Fisher Scientific Inc.; IQVIA Inc.; ICON Public Limited Company; Eurofins Scientific SE; Piramal Pharma Limited; Almac Group Limited; Wasdell Group Limited; Clinigen Group plc; Inceptua Group B.V.; Ancillare LP; Veristat LLC; BAP Pharma Holding Limited; Oximio Group Limited; Tanner Pharma Group Limited; Spring BioSolution Ltd.; N-SIDE S.A.

North America was the largest region in the comparator sourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comparator sourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the comparator sourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The comparator sourcing market includes revenues earned by entities by providing services such as identification and procurement of reference products, regulatory-grade comparator supply, cold-chain logistics and distribution, authentication and traceability management, quality verification, documentation and compliance support, and inventory management of comparator materials. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The comparator sourcing market research report is one of a series of new reports from The Business Research Company that provides comparator sourcing market statistics, including comparator sourcing industry global market size, regional shares, competitors with a comparator sourcing market share, detailed comparator sourcing market segments, market trends and opportunities, and any further data you may need to thrive in the comparator sourcing industry. This comparator sourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Comparator Sourcing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses comparator sourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for comparator sourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The comparator sourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Branded Drugs; Generic Drugs; Biosimilars; Biologics
• 2) By Therapeutic Area: Oncology; Cardiovascular Diseases; Neurology; Infectious Diseases; Immunology; Respiratory Diseases; Other Therapeutic Areas
• 3) By Sourcing Type: Local Sourcing; Global Sourcing
• 4) By Application: Clinical Trials; Bioequivalence Studies; Research And Development; Other Applications
• 5) By End User: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes
• Subsegments:
• 1) By Branded Drugs: Innovative Oncology Drugs; Cardiovascular Reference Drugs; Specialty Patent Protected Medicines; Central Nervous System Drugs
• 2) By Generic Drugs: Oral Solid Dosage Generics; Injectable Generic Medicines; Over The Counter Generic Drugs; Low Cost Therapeutic Alternatives
• 3) By Biosimilars: Monoclonal Antibody Biosimilars; Insulin Biosimilars; Autoimmune Disease Biosimilars; Oncology Biosimilar Products
• 4) By Biologics: Recombinant Protein Therapies; Cell And Gene Therapies; Vaccines And Immunotherapies; Plasma Derived Biological Products
• Companies Mentioned: Thermo Fisher Scientific Inc.; IQVIA Inc.; ICON Public Limited Company; Eurofins Scientific SE; Piramal Pharma Limited; Almac Group Limited; Wasdell Group Limited; Clinigen Group plc; Inceptua Group B.V.; Ancillare LP; Veristat LLC; BAP Pharma Holding Limited; Oximio Group Limited; Tanner Pharma Group Limited; Spring BioSolution Ltd.; N-SIDE S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Comparator Sourcing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Comparator Sourcing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Comparator Sourcing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Comparator Sourcing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Regulatory Grade Reference Standards In Pharmaceutical Development
  • 4.2.2 Increasing Outsourcing Of Comparator Sourcing To Contract Research Organizations
  • 4.2.3 Growing Complexity Of Bioequivalence And Analytical Testing Requirements
  • 4.2.4 Expansion Of Global Clinical Trial Activities Across Emerging Markets
  • 4.2.5 Increasing Adoption Of Standardized Quality Validation Frameworks In Drug Development

5. Comparator Sourcing Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Contract Research Organizations
• 5.4 Academic And Research Institutes
• 5.5 Regulatory Agencies

6. Comparator Sourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Comparator Sourcing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Comparator Sourcing PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Comparator Sourcing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Comparator Sourcing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Comparator Sourcing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Comparator Sourcing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Comparator Sourcing Market Segmentation

• 9.1. Global Comparator Sourcing Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Branded Drugs, Generic Drugs, Biosimilars, Biologics
• 9.2. Global Comparator Sourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Cardiovascular Diseases, Neurology, Infectious Diseases, Immunology, Respiratory Diseases, Other Therapeutic Areas
• 9.3. Global Comparator Sourcing Market, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Local Sourcing, Global Sourcing
• 9.4. Global Comparator Sourcing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Trials, Bioequivalence Studies, Research And Development, Other Applications
• 9.5. Global Comparator Sourcing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes
• 9.6. Global Comparator Sourcing Market, Sub-Segmentation Of Branded Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Innovative Oncology Drugs, Cardiovascular Reference Drugs, Specialty Patent Protected Medicines, Central Nervous System Drugs
• 9.7. Global Comparator Sourcing Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Solid Dosage Generics, Injectable Generic Medicines, Over The Counter Generic Drugs, Low Cost Therapeutic Alternatives
• 9.8. Global Comparator Sourcing Market, Sub-Segmentation Of Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoclonal Antibody Biosimilars, Insulin Biosimilars, Autoimmune Disease Biosimilars, Oncology Biosimilar Products
• 9.9. Global Comparator Sourcing Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Recombinant Protein Therapies, Cell And Gene Therapies, Vaccines And Immunotherapies, Plasma Derived Biological Products

10. Comparator Sourcing Market Regional And Country Analysis

• 10.1. Global Comparator Sourcing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Comparator Sourcing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Comparator Sourcing Market

• 11.1. Asia-Pacific Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Comparator Sourcing Market

• 12.1. China Comparator Sourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Comparator Sourcing Market

• 13.1. India Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Comparator Sourcing Market

• 14.1. Japan Comparator Sourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Comparator Sourcing Market

• 15.1. Australia Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Comparator Sourcing Market

• 16.1. Indonesia Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Comparator Sourcing Market

• 17.1. South Korea Comparator Sourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Comparator Sourcing Market

• 18.1. Taiwan Comparator Sourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Comparator Sourcing Market

• 19.1. South East Asia Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Comparator Sourcing Market

• 20.1. Western Europe Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Comparator Sourcing Market

• 21.1. UK Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Comparator Sourcing Market

• 22.1. Germany Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Comparator Sourcing Market

• 23.1. France Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Comparator Sourcing Market

• 24.1. Italy Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Comparator Sourcing Market

• 25.1. Spain Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Comparator Sourcing Market

• 26.1. Eastern Europe Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Comparator Sourcing Market

• 27.1. Russia Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Comparator Sourcing Market

• 28.1. North America Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Comparator Sourcing Market

• 29.1. USA Comparator Sourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Comparator Sourcing Market

• 30.1. Canada Comparator Sourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Comparator Sourcing Market

• 31.1. South America Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Comparator Sourcing Market

• 32.1. Brazil Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Comparator Sourcing Market

• 33.1. Middle East Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Comparator Sourcing Market

• 34.1. Africa Comparator Sourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Comparator Sourcing Market, Segmentation By Product Type, Segmentation By Therapeutic Area, Segmentation By Sourcing Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Comparator Sourcing Market Regulatory and Investment Landscape

36. Comparator Sourcing Market Competitive Landscape And Company Profiles

• 36.1. Comparator Sourcing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Comparator Sourcing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Comparator Sourcing Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. IQVIA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. ICON Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Piramal Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

37. Comparator Sourcing Market Other Major And Innovative Companies

• Almac Group Limited, Wasdell Group Limited, Clinigen Group plc, Inceptua Group B.V., Ancillare LP, Veristat LLC, BAP Pharma Holding Limited, Oximio Group Limited, Tanner Pharma Group Limited, Spring BioSolution Ltd., N-SIDE S.A.

38. Global Comparator Sourcing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Comparator Sourcing Market

41. Comparator Sourcing Market High Potential Countries, Segments and Strategies

• 41.1 Comparator Sourcing Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Comparator Sourcing Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Comparator Sourcing Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer